In contrast to previous studies [16], we did not observe an increase in afamin, clusterin, VDBP, or A1AT in the serum of tumor-bearing gp130Y757F mice versus wild-type in either early- or late-stage diseases (Figure 2A–D). This evidence concerns the gene AFM and neoplasm.